Dermapharm Stock - Chart picture around the 200-day line

Dermapharm stock trades in a narrow range as investors watch the technical picture around the 200-day moving average and the SDAX pharma peer group. Thursday’s focus is on chart levels and recent volatility rather than fresh corporate news.

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 18:07 CET. Details in the imprint.

Dermapharm (DE000A2GS5D8) remains a mid-cap German pharmaceuticals stock in the SDAX with a relatively stable chart this week. With no new corporate releases or analyst updates confirmed today, Thursday’s focus shifts to the technical picture and recent trading range.

What the chart shows now

Dermapharm shares trade on Xetra under ticker DMP, with the quote hovering in a relatively tight corridor over recent sessions, according to Xetra data. Volumes remain moderate, consistent with the stock’s SDAX mid-cap profile and its mainly domestic investor base.

On the daily chart, Dermapharm is trading not far from its 200-day moving average, a level many technical investors monitor as a medium-term trend indicator. Price swings over the past month have been contained, suggesting muted short-term volatility compared with more cyclical sectors.

Thursday focus on technicals

With no fresh ad-hoc announcements or broker notes today, traders focus on support and resistance zones visible in the recent trading range. Short-term support can be derived from the last local lows, while the recent swing highs mark the next resistance band for chart-oriented investors.

Against this backdrop, Dermapharm’s chart currently looks orderly rather than dynamic, fitting a defensive healthcare name. The stock’s membership in the SDAX means it can still be influenced by broader small and mid-cap flows on the German market.

How the company makes money

Dermapharm Holding SE develops and manufactures off-patent branded pharmaceuticals, herbal medicines and healthcare products, with a focus on German-speaking and European markets. The group also runs a contract development and manufacturing business that produces for third-party pharma and wellness clients.

Where the stock trades today

The shares of Dermapharm (DE000A2GS5D8) trade on Xetra at EUR 44.00 as of 06/18/2026, 17:55 CET.

Key facts on Dermapharm stock

• Company: Dermapharm Holding SE
• ISIN: DE000A2GS5D8
• WKN: A2GS5D
• Ticker: DMP
• Venue: Xetra
• Price (as of 06/18/2026, 17:55 CET): 44.00 EUR
• Market cap: 2,350,000,000 EUR (as of 06/18/2026)
• Sector / Industry: Health Care / Pharmaceuticals
• Index membership: SDAX
• Next earnings date: 08/29/2026

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.